They can also directly recognize cancer cells expressing MHC II [87] or even kill cancer cells [89], as in HR+/HER2− BC patients treated with an induction phase of CT followed by nivolumab + HT, stromal Granzyme+ CD4+ T cells were enriched, as a result, after exposure to ICI [23]. Here, ERBB2 is linked to breast cancer.